Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amrize (AMRZ) Cash & Equivalents (2024 - 2025)

Amrize (AMRZ) has disclosed Cash & Equivalents for 2 consecutive years, with $1.9 billion as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 21.26% to $1.9 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.9 billion through Dec 2025, up 21.26% year-over-year, with the annual reading at $1.9 billion for FY2025, 21.26% up from the prior year.
  • Cash & Equivalents hit $1.9 billion in Q4 2025 for Amrize, up from $826.0 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.9 billion in Q4 2025 to a low of $601.0 million in Q2 2025.